Funding for this research was provided by:
Horizon 2020 (DLV-719500)
Article History
Received: 4 April 2018
Accepted: 10 June 2018
First Online: 25 June 2018
Compliance with ethical standards
:
: Eleni Fotiadou is funded by EU Horizon 2020 (grant number DLV-719500). Rik Vullings has shares in Nemo Healthcare BV, The Netherlands.